hope better day
rate equal-weight construct
advantag categori exposur innov pipelin pf
synergi potenti howev face greater execut
risk due emerg competit headwind legaci
busi on-going top-line challeng pf
takeaway stock trade vs disappoint
result miss organ sale growth expect vs consensu
lead ep shortfal vs consensu pf result
in-lin expect org sale legaci
pressur due sever discreet headwind weak result particularli
surpris follow posit tone investor day mid-quart
reduc investor confid despit miss maintain net
revenu outlook call organ sale growth vs prior
due lower base reduc ep rang
reflect recent gelit divestitur cautiou organ sale
guidanc mse see ep achiev due pf synergi
top-line headwind like continu near-term competit activ remain
elev legaci top-line impact four discreet headwind
aros toward end quarter includ elev privat label
competit can tomato hunt ii greater promot activ
can pasta boyarde iii merchandis setback mari callend
iv manufacturing/co packer issu manag confid issu
transient view current competit dynam unsustain howev
like linger impact competit remain elev
select step-up price invest preserv market share
snack remain sourc strength retail take-away
place greater onu top-line recoveri alway expect
back end weight weaker start year place even greater onu
recoveri see acceler sale growth second half
due strong innov pipelin pf initi start appear
food unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
shelf uplift snack follow octob nac show model total
compani organ sale growth compani guidanc
reflect continu weak org sale
improv org sale driven robust innov
pipelin abat competit headwind expect acceler ep growth
driven improv top-line synergi realiz debt paydown
buy opportun screen attract consid
inexpens valuat ev/ebitda manag derisk
near-term outlook pf synergi provid multi-year ep tailwind long-term
well-posit categori standpoint rel peer howev
remain sidelin due potenti risk emerg competit
guidanc high leverag reduc pt vs prior
reflect ev/ebitda discount center-stor peer given
face increas competit pressur rel high leverag
pt base ev/ebitda discount peer
take account higher ep growth outlook
leverag plu valu tax asset
bull case ev/ebitda plu valu tax asset
bull case ev/ebitda plu valu tax asset
sale recoveri synergi ahead plan ad strateg option pf
sale recoveri progress faster expect result pf sale
growth legaci deliv acceler organ sale
year synergi upsid drive bp cumul ebit margin
improv valuat re-rat reflect potenti margin
earn upsid
base ev/ebitda plu valu tax asset
base ev/ebitda plu valu tax asset
deliveri outlook drive re-rat legaci deliv strong organ
sale turn around sale trend pf flat yoy
ebit margin expans bp
assum synergi captur ep benefit on-going
debt paydown forecast project ep
bear ev/ebitda plu valu tax asset
bear ev/ebitda plu valu tax asset
legaci busi pressur pf remain challeng top-line
weak across legaci busi organ sale
result greater reinvest margin expans pf
sale declin yoy synergi realiz
reinvest essenti save back busi
advantag top-line growth outlook
legaci abl sustain
lsd organ sale growth due exposur
frozen opportun turnaround
refriger busi growth snack
reduc fundament visibl
manag strong turnaround track
record see greater risk pf
see solid hsd ep growth limit
potenti upsid mid-term
target opportun close
gross margin gap vs peer compani
set optimist target risk
downsid top-line synergi estim
valuat ev/ebitda reflect
compani rel higher leverag
top-line recoveri pinnacl food
greater expect synergi realiz
strong momentum legaci busi
potenti divestitur acceler debt
risk achiev price
continu organ sale weak pf
signific reinvest cost synergi
exhibit us retail organ sale decreas bp
scanner
exhibit organ sale driven volum declin
exhibit gm decreas
exhibit ebit margin decreas
exhibit percentag sale
advertis promot expens
exhibit trade low end among food compani
good sold
sg sale
incom continu oper
net incom attribut conagra
cash equival
prepaid expens ca
current asset held sale
properti plant equip net
trademark intang
non-current asset held sale
current instal long-term debt
current liabil held sale
non-current liabilti held sale
accumul comprehens incom loss
total liabil stockhold equiti
flow oper activit
incom continu oper
adjust reconcil incom
depreci amort
chang oper asset liabil
prepaid expens current asset
oper continu
oper discontinu
oper activ
flow invest activ
addit pp
sale busi em invest
sale properti plant equip
purchas busi
proce collect
invest continu
invest discontinu
invest activ
flow financ activ
issuanc long-term debt
repay long-term debt net
issuanc common share
repurchas common share
exercis employe option
financ continu
financ discontinu
financ activ
effect fx cash cash equival
discontinu oper cash activ includ
add held sale beg year
less held sale year end
net decreas /increas cash
equival beg year
equival end year
